4.2 Review

Fibrocytes in health and disease

Journal

EXPERIMENTAL HEMATOLOGY
Volume 38, Issue 7, Pages 548-556

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2010.03.004

Keywords

-

Funding

  1. Department of Internal Medicine (New Haven, CT, USA)

Ask authors/readers for more resources

Fibrocytes are circulating mesenchymal progenitor cells that participate in tissue responses to injury and invasion. Accumulating knowledge from animal models regarding the differentiation, trafficking, and function of these cells implicates them in the development of diseases characterized by chronic inflammation and excessive collagen deposition. Recent data obtained from the clinical setting suggests that the enumeration of circulating fibrocytes may be a biomarker for disease progression in chronic lung diseases including asthma and pulmonary fibrosis. A greater understanding of the immunologic mediators that influence fibrocyte biology suggests new opportunities for therapeutic manipulation of these cells in fibrogenesis. This review integrates new developments in the cellular and molecular biology of fibrocytes with current concepts regarding the etiopathogenesis of fibrosing disorders. (C) 2010 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available